be_ixf;ym_202111 d_26; ct_50

Select Page
ARKG charts & data provided by TradingView

Latest Insights on ARKG

biotech stocks to buy 3 Biotech Innovations Driving America 2.0 Stocks Up
by Nick Tate November 4, 2021 Bold Profits Daily, Investment Opportunities, Technology
The genetics-biotech revolution is remaking our $16 trillion health care industry. Here’s how to upgrade your portfolio for America 2.0 medicine.
CRISPR technology cannabis boost This Hot Tech Will Unleash a Cannabis Boom
by Steve Fernandez July 27, 2021 Cannabis, Technology, Winning Investor Daily
One incredible technology will improve the efficiency of growing operations and unlock higher profit margins for cannabis companies.
1 ETF to Buy Before Next 547% Gain in Genetics Testing
by Nick Tate March 18, 2021 Bold Profits Daily, Investment Opportunities, Technology
When the price for an in-demand tech product drops this much it’s the trigger for phenomenal gains.
7 Mega Trend Trades for 2021
by Amber Lancaster December 23, 2020 Bold Profits Daily, Investment Opportunities, Trading Strategies
I’m giving you seven ways to play our big America 2.0 mega trends for 2021.
10X Your Pink DNA Dollars with 1 Catalyst
by Nick Tate October 1, 2020 Bold Profits Daily, Investment Opportunities, Stocks
A new “targeted therapy” treatment — a catalyst for its stock — is a great move for the $217 billion precision medicine market.

Newsletter Sign Up

Sponsored

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."

- Will O.

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

Share This